作者: Ian A Blair , Clementina Mesaros , Patrick Lilley , Matthew Nunez
关键词:
摘要: BluePen Biomarkers provides a unique comprehensive multi-omics biomarker discovery and validation platform. We can quantify, integrate analyze genomics, proteomics, metabolomics lipidomics biomarkers, alongside clinical data, demographics other phenotypic data. A bio-inspired signal processing analytic approach is used that has the proven ability to identify biomarkers in wide variety of diseases. The resulting be for diagnosis, prognosis, mechanistic studies predicting treatment response, contexts from core research through trials. an additional groundbreaking goal: identifying surrogate different modalities. This not only new biological insights, but enables least invasive, least-cost tests meet or exceed predictive quality current tests.